Atherosclerosis Drugs Market Value

Atherosclerosis Drugs Market – Risk Associated with Cardiovascular Health to Drive Sales Despite the prevalence of diabetes and cholesterol among a wide patient pool, the atherosclerosis drugs market will move at a sluggish CAGR of 2.5% during the forecast period, finds a recently published report by Transparency Market Research (TMR). This market growth is attributable to the […]